$20.15
-0.14 (-0.69%)
Insulet Corp (NASDAQ:PODD)
CAPS Rating:
Dvlp,mftr,mkt insulin infusion system for diabetes
Dvlp,mftr,mkt insulin infusion system for diabetes
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
I use there product and it is far superior to all of the other insulin pumps on the market. I have also seen that they are teaming up with several other companies to produce new products such as a combined pump and CGM that may combine the insulin pump and the CGM sensor so you only have to have one thing stuck on your body. That would be a relief for people like me who don't want to stick two things to their bodes.Also I think that the innovative thinking that made them the first tubeless pump will help guide them to make more improvements to their product.I think the worst case scenario is they get bought by some larger company like Medtronic or Abbott.